A novel SPECT/CT acquisition method can accurately detect radiopharmaceutical biodistribution in a convenient manner for prostate cancer patients, opening the door for more personalized treatment.
A University of Illinois and Mayo collaboration has demonstrated a novel gene expression analysis technique that can accurately measure levels of RNA quickly and directly from a cancerous tissue ...
C11-acetate PET for docetaxel prednisone (DP) response assessment in castrate-resistant prostate cancer (CRPC). Background: Docetaxel is a standard treatment for hormone-refractory prostate cancer.
Treatment options for localized prostate cancer are many and varied, ranging from immediate radical surgery through to observation alone. Radical prostatectomy has been shown to have an overall ...
Scientists at the Karolinska Institute in Sweden recently reported that magnetic resonance imaging (MRI) could reduce overdiagnosis and thereby improve prostate cancer screening. Now, the same team ...
A University of Illinois and Mayo collaboration has demonstrated a novel gene expression analysis technique that can accurately measure levels of RNA quickly and directly from a cancerous tissue ...
In 2014, prostate cancer was the leading cause of newly diagnosed cancers in men and the second leading cause of cancer death in men. A team of scientists and physicians now describe a novel imaging ...
Technology to perform prostate biopsies has been relatively unchanged since the 1980's. Traditional techniques only sample the lower portion of the prostate, yet nearly 30 percent of cancers are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results